SCHEMBL13740667

SCHEMBL13740667

O=c1cc(-c2[nH]c(Cl)nc2-c2ccccc2)cc[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.54
MAPK13 O15264 6/20 0.44
MAPK12 P53778 6/20 0.44
MAPK11 Q15759 6/20 0.44
MAPK14 Q16539 6/20 0.44
HPGD P15428 4/20 0.41
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 2/20 0.40
ALDH1A1 P00352 2/20 0.39
XDH P47989 1/20 0.39
MEN1 O00255 1/20 0.39
CASP1 P29466 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RAF1 P04049 4/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GCGR P47871 1/20 0.37
MAPK9 P45984 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4105858 0.86 MAPK13 (0.60) NOTUMMAPK13MAPK12MAPK11MAPK14
SCHEMBL13741481 0.85 CYP19A1 (0.44) NOTUMMAPK13MAPK12MAPK11MAPK14
SCHEMBL13740498 0.83 HPGD (0.64) NOTUMMAPK13MAPK12MAPK11MAPK14
Trifluoroacetic Acid SCHEMBL4092771 0.80 L3MBTL1 (0.41) NOTUMMAPK13MAPK12MAPK11MAPK14
SCHEMBL8221938 0.79 KDM4E (0.60) MAPK13MAPK12MAPK11MAPK14HPGD
SCHEMBL5762068 0.79 MAPK13 (0.68) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL5759775 0.78 MAPK14 (0.61) MAPK13MAPK12MAPK11MAPK14KMT2A
SCHEMBL3618734 0.74 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL1136802 0.72 NOTUM (1.00) NOTUMKDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL13741397 0.71 MAPK13 (0.49) MAPK13MAPK12MAPK11MAPK14HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215766-A1 TETRACYCLIC INHIBITORS OF JANUS KINASES INCYTE CORPORATION 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215766-A1 TETRACYCLIC INHIBITORS OF JANUS KINASES JAK1, JAK2, JAK3 NOTUM 3935/4885MAPK13 99/4885MAPK12 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.